COMPOSITIONS OF NEISSERIA MENINGITIDIS AND METHODS FOR PREPARATION THEREOF Russian patent published in 2020 - IPC A61K39/95 A61K39/295 C07K14/22 

Abstract RU 2723045 C2

FIELD: biotechnology.

SUBSTANCE: invention relates to the field of biotechnology. Described is the use of an effective amount of a composition of rLP2086 N. meningitidis and three additional immunogenic compositions together for inducing a bactericidal immune response against a strain of subfamily A N. meningitidis serogroup B and against a strain of subfamily B N. meningitidis serogroup B in a human. Said rLP2086 N. meningitidis composition contains a) a first lipidated polypeptide comprising an amino acid sequence presented by SEQ ID NO: 1, and b) a second lipid polypeptide comprising an amino acid sequence presented by SEQ ID NO: 2. As an additional immunogenic composition, (i) an immunogenic composition for the strain of Neisseria meningitidis serogroup A, Neisseria meningitidis strain of serogroup C, Neisseria meningitidis strain of serum group Y and/or Neisseria meningitidis strain of serogroup W135; (ii) an immunogenic composition for diphtheria, tetanus and pertussis; and (iii) an immunogenic composition for human papilloma virus.

EFFECT: invention extends the range of methods for inducing a bactericidal immune response against the serogroup B subfamily A N. meningitidis strain and against the serous B group N. meningitidis subfamily B strain.

26 cl, 2 dwg, 26 tbl, 15 ex

Similar patents RU2723045C2

Title Year Author Number
NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS FOR USING THEM 2017
  • Anderson Annaliesa Sybil
  • Hoiseth Susan Kay
  • Jansen Kathrin Ute
  • Moran Justin Keith
  • Ruppen Mark E.
RU2739504C2
IMMUNOGENIC COMPOSITION FOR NEISSERIA MENINGITIDIS (OPTIONS) 2014
  • Anderson Annaliza Sibil
  • Arumugkham Rasappa Gounder
  • Farlej Dzhon Ervin
  • Fletcher Lia Dajen
  • Kharris Shennon
  • Dzhensen Ketrin Yute
  • Dzhons Tomas Richard
  • Kkhandke Lakshmi
  • Loun Bounton
  • Perez Dzhon Lens
  • Zlotnik Gari Uorren
RU2662968C2
METHODS FOR INCREASING VACCINE EFFICIENCY BY INJECTING IL-4R ANTAGONIST 2017
  • Purcell Ngambo, Lisa
  • Graham, Neil
  • Murphy, Andrew J.
  • Evans, Robert
RU2753869C2
FMDV RECOMBINANT VACCINES AND USE THEREOF 2015
  • Audonnet, Jean-Christophe
  • Hannas-Djebbara, Zahia
  • Mebatsion, Teshome
  • Chiang, Yu-Wei
  • Widener, Justin
  • Reynard, Frederic
RU2745373C2
VERSIONS OF FACTOR N-BINDING PROTEIN AND METHODS OF USE THEREOF 2015
  • Birnink Piter T.
RU2714248C2
OPTIONS FOR H-BINDING PROTEIN FACTOR AND METHODS OF THEIR USE 2015
  • Beernink, Peter T.
RU2811942C2
VACCINE AGAINST FELINE CALICIVIRUS 2018
  • Tarpey, Ian
RU2792898C2
IMMUNOGENIC COMPOSITIONS OF GLYCOPROTEIN G OF HENDRA AND NIPAH VIRUSES 2012
  • Elhay, Martin
  • Broder, Christopher, C.
  • Huang, Jin-An
RU2787820C2
ADVANCED CORONAVIRUS VACCINE 2022
  • Wong, Chi-Huey
  • Ma, Che
  • Huang, Han-Yi
RU2816182C2
MODIFIED PROTEIN BINDING FACTOR H 2017
  • Tan, Kristof M
RU2773464C1

RU 2 723 045 C2

Authors

Anderson, Annaliesa Sybil

Arumugham, Rasappa Gounder

Farley, John Erwin

Fletcher, Leah Diane

Harris, Shannon

Jansen, Kathrin Ute

Jones, Thomas Richard

Khandke, Lakshmi

Loun, Bounthon

Perez, John Lance

Zlotnick, Gary Warren

Dates

2020-06-08Published

2016-02-16Filed